Andy Coravos is the CEO/co-founder of Elektra Labs, building a digital medicine platform for decentralized clinical trials. She serves as a research collaborator at the Harvard-MIT Center for Regulatory Sciences. Formerly, she served as an Entrepreneur in Residence at the FDA working in the Digital Health Unit (DHU), focusing on the Pre-Cert program and policies around software-as-a-medical-device and AI/ML. Previously, Andy worked as a software engineer at Akili Interactive Labs, a leading digital therapeutic company. She serves on the Board of the Digital Medicine Society (DiMe), and she’s an advisor to the Biohacking Village at DEF CON.